Search results
Newswise Expert | Daniel Petrylak, Yale Cancer Center/Smilow Cancer Hospital
Newswise· 17 hours agoDaniel P. Petrylak is a pioneer in the research and development of new drugs and treatments to fight prostate, bladder, kidney and testicular cancer. For ...
Top 10 most common cancers among Blacks
Rolling Out· 1 day agoUnderstanding the most common cancers among African Americans is crucial for improving prevention, early detection, and treatment strategies.
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 hours agoSELECT is a radiogenomics study intended to evaluate lesion concordance between 68Ga (gallium)-based PSMA-PET4 imaging and TLX591 dosimetry for the purpose of validating PET imaging for patient ...
Why I Told the World I Was Living With Cancer
Level Man via Yahoo News· 5 days agoOn April 5 of 2023 , I received life-altering news, some of which I am still processing. I was diagnosed with stage 1 prostate cancer. It was caught very...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 7 days agoJNJ-6420 is an anti-hK2 antibody-based targeted radioligand therapy that's designed to deliver a...
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
Zacks via Yahoo Finance· 3 days agoCandel (CADL) surges 431% in the year-to-date period, driven by positive developmental and...
AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024
Morningstar· 3 days agoData From Newly FDA-Approved IMDELLTRA™ (tarlatamab-dlle) Further Reinforce Leadership in Bispecific T-Cell Engagers Overall Survival Data from Phase 3 LUMAKRAS® (sotorasib ...
ASCO: Large precision oncology study identifies di | Newswise
Newswise· 7 days agoA new study led by a UCLA-VA collaborative team looking at the landscape of genomic alterations in more than 5,000 veterans with metastatic prostate cancer
Cancer can be caused by reversible molecular changes – as new study shows
The Conversation· 2 days agoThis theory posits that DNA mutations are the primary cause of cancers. It’s well known that ageing, as well as some lifestyle and environmental factors (such as smoking and ...
... in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to...
FOX 5 San Diego· 7 days agoRakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy based on its proprietary Alluminox™ platform ...